Replies for peers. Need ONE Response Per Each Discussion Total 2 Responses. Attached Are The Discussions And Rubric Please Follow Them. Posts Will Be A Min

Replies for peers. Need ONE Response Per Each Discussion Total 2 Responses. Attached Are The Discussions And Rubric Please Follow Them. Posts Will Be A Min

Click here to Order a Custom answer to this Question from our writers. It’s fast and plagiarism-free.

Replies for peers. Need ONE Response Per Each Discussion Total 2 Responses. Attached Are The Discussions And Rubric Please Follow Them. Posts Will Be A Minimum Of 100 Words, APA Format.One Reference Per Each Discussion Amniellys Rodriguez
Health Care Policy

Use of cannabis for medicinal purposes has generated a lot of attention at the national and international level. There are a lot of controversies revolving around ethical, legal and other implications of use of marijuana. Adverse health effects as well as deaths related to cannabis are some of complex issues related to cannabis. Cannabis is currently recognized as schedule I controlled drugs. It has a high potential of abuse, not accepted for medicinal treatment in the U.S and does not have accepted safety data for it use in treatment under medical supervision (Bridgeman & Abazia, 2017).
One of the stakeholders opposing cannabis use is the law enforcement agencies. In some states, it has become legal to use cannabis, but the police officer’s attitude has not changed regarding the use of cannabis. Another stakeholder opposing cannabis is the big pharmaceutical companies. Such companies are known to run huge operations of conventional medications and as such are in the forefront of opposing the therapeutic benefits of cannabis (Alice, 2018). Lastly is private prisons which feel that legalization of marijuana will lead to less convicts and as such this will reduce their business (Alice, 2018). Stakeholders who are in support of cannabis use for medicinal purposes include citizens and patients. Legalization for medicinal use commonly affects the citizens. There are a variety of applications that cannabis has been said to have for a variety of diseases. Instead of using prescriptions that can have side effects, patients and citizens can use cannabis. Others in support include medical and pharmaceutical communities. These are likely to benefit in handling the ever growing medical needs and offering more options to the patients.
There has been an increase in the public debate and research over the pharmacological qualities and effects of marijuana. Most of the research on the use of cannabis for medicinal purposes conclude with a call for further clinical trials (De Vries & Green, 2017). Use of cannabis in oncology is mainly focused on symptoms management such as vomiting and nausea which is associated with chemotherapy (De Vries & Green, 2017). Given this and the fact that there is growing evidence of cannabis potential benefit of slowing neurodegenerative disorders, cannabis use has significantly grown.
Reports shows that there is increased use of cannabinoids in treatment of neurodegenerative diseases and other life-limiting conditions. There is also increased use of cannabis use for therapeutic benefits from illegal consumptions (De Vries & Green, 2017). With increased legalization and approval for medicinal use, there will be widespread use of marijuana for medicinal purposes. In future, more policies will be created to regulate cannabis medical use as well as more states will legalize the use of cannabis. Nurses at some points will be advocating for use of cannabis in patients.

Alice. (2018, July 6). Stakeholders that oppose cannabis legalization – I love growing marijuana. Retrieved from

Bridgeman, M. B., & Abazia, D. T. (2017). Medicinal cannabis: History, pharmacology, and implications for the acute care setting. Pharmacy and Therapeutics, 42(3), 180.

De Vries, K., & Green, A. J. (2017, February 24). Therapeutic use of cannabis. Retrieved from

Seth Lesperance D. Paurice

Cannabis Use in Medicine
Cannabis, also known as medicinal marijuana is a plant-based, highly trafficked, and widely cultivated illicit drug that is well known across the globe. This drug, whose origin traces back to the olden times, has gained lots of attention with regard to its medicinal value and properties, in the recent years. The Comprehensive Drug Abuse Prevention and Control Act by the US Drug Enforcement Agency, has lately recognized marijuana as a Schedule I controlled substance under careful medical administration and supervision (Bridgeman and Abazia, 2017). The use of cannabis is widely employed to treat chronic pain that are associated with neuropathic diseases, fibromyalgia, severe migraine, rheumatoid arthritis, and so on (Mallick-Searle and St. Marie, 2019). Amidst these advantages, they are found to be harmful when taken as heavy doses by leading to various side effects such as short-term memory, psychotic symptoms, anxiety, depression, suicidal tendencies, lung diseases, and many more (Tikka and D’Souza, 2018).
The stakeholders who support the use of cannabis in medicine is the American Society of Addiction Medicine through its public policy statement on the medical and the non-medical usage of cannabis that are observed under their specially framed criteria (American Society of Addiction Medicine, 2020). Apart from this, those who are associated with cannabis farming, firms that deliver its information, and usage, also acts as stakeholders who supports the medical use of cannabis. These stakeholders who support the medicinal use of cannabis claim about the lack of negative impacts with safe and right usage of drug dosages in treating a specific health condition. Similarly, the stakeholder who opposes the medical use of cannabis include the American cancer Society, who instead has opted for carrying out further research investigations for its clear and well-defined values and properties to be used in medicine, despite its negative consequences that it imposes upon certain cancer patients (American Cancer Society, 2020). Other stakeholders who oppose this includes those politicians and members who gain profits with the prohibition of cannabis. These stakeholders, who oppose the drug usage claim that the excessive use of drugs lead to addiction and many more psychiatric symptoms.
With regard to the increased use of medicinal cannabis, it has been found that the cultivation of cannabis plant and its distribution, regulation, and proper usage is more complex. Usage of cannabis in medicine has caused great effects in alleviating pain and in suppressing various complex symptoms, post-traumatic stress disorders, elimination of vomiting, nausea, and neurological conditions as in epilepsy with the intake of oral cannabis (Mallick-Searle and St. Marie, 2019). Even though there are several research studies that has proved the use of cannabis in generating positive health outcomes, there are certain area, in which the usage of cannabis in medicine has proved to create negative impacts. There are certain studies which have also proven the effective properties of cannabis in healing various diseases more than the other healing drugs. Besides this, the increased use of this drug at higher dosages are found to cause various psychological health effects and mental disorders which when left un-addressed leads to huge economic loss (Tikka and D’Souza, 2018).
The policy and future practice indications that are based on the current prescribed use of cannabis are its negative impacts that it imposes upon the people in palliative care units and among those who are undergoing debilitating chronic health conditions. Even though the use of cannabis is legalized, it has been found to be unnecessary by the US Justice department and has not been found to have a proper federal priority. This condition discourages many physicians to prescribe cannabis to treat medical conditions among the patients. One country that has legalized the use of cannabis to prescribe for medical conditions is Canada. This legalization also raises the risk of cannabis drug abuse among the people in the country in days to come wherein people might use the legalization policy of this drug to be used as drug abuse (Fedorova et al., 2019).
American Cancer Society. (2020, August 4). Marijuana and cancer. American Cancer Society. Retrieved November 22, 2021, from
American Society of Addiction Medicine. (2020, October 10). American Society of Addiction Medicine. Cannabis. Retrieved November 22, 2021, from
Bridgeman, M. B., & Abazia, D. T. (2017). Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting. Pharmacy and Therapeutics: A Peer-Reviewed Journal for Managed Care and Hospital Formulary Management, 42(3), 180–188.
Fedorova, E. V., Schrager, S. M., Robinson, L. F., Cepeda, A., Wong, C. F., Iverson, E., & Lankenau, S. E. (2019). Illicit drug use and prescription drug misuse among young adult medical cannabis patients and non-patient users in Los Angeles. Drug and Alcohol Dependence, 198, 21–27.
Mallick-Searle, T., & St. Marie, B. (2019). Cannabinoids in pain treatment: An overview. Pain Management Nursing, 20(2), 107–112.
Tikka, S. K., & D’Souza, D. C. (2018). The association between Cannabinoids and Psychosis. Cannabis Use Disorders, 127–155.

Place your order now for a similar assignment and have exceptional work written by one of our experts, guaranteeing you an A result.

Need an Essay Written?

This sample is available to anyone. If you want a unique paper order it from one of our professional writers.

Get help with your academic paper right away

Quality & Timely Delivery

Free Editing & Plagiarism Check

Security, Privacy & Confidentiality